Correlation Between Propanc Biopharma and Brainsway

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Propanc Biopharma and Brainsway at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Propanc Biopharma and Brainsway into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Propanc Biopharma and Brainsway, you can compare the effects of market volatilities on Propanc Biopharma and Brainsway and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Propanc Biopharma with a short position of Brainsway. Check out your portfolio center. Please also check ongoing floating volatility patterns of Propanc Biopharma and Brainsway.

Diversification Opportunities for Propanc Biopharma and Brainsway

-0.24
  Correlation Coefficient

Very good diversification

The 3 months correlation between Propanc and Brainsway is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Propanc Biopharma and Brainsway in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Brainsway and Propanc Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Propanc Biopharma are associated (or correlated) with Brainsway. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Brainsway has no effect on the direction of Propanc Biopharma i.e., Propanc Biopharma and Brainsway go up and down completely randomly.

Pair Corralation between Propanc Biopharma and Brainsway

Given the investment horizon of 90 days Propanc Biopharma is expected to generate 14.8 times more return on investment than Brainsway. However, Propanc Biopharma is 14.8 times more volatile than Brainsway. It trades about 0.14 of its potential returns per unit of risk. Brainsway is currently generating about 0.04 per unit of risk. If you would invest  1,200  in Propanc Biopharma on November 30, 2024 and sell it today you would lose (525.00) from holding Propanc Biopharma or give up 43.75% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Propanc Biopharma  vs.  Brainsway

 Performance 
       Timeline  
Propanc Biopharma 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Propanc Biopharma are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak fundamental indicators, Propanc Biopharma sustained solid returns over the last few months and may actually be approaching a breakup point.
Brainsway 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Brainsway has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Brainsway is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Propanc Biopharma and Brainsway Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Propanc Biopharma and Brainsway

The main advantage of trading using opposite Propanc Biopharma and Brainsway positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Propanc Biopharma position performs unexpectedly, Brainsway can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brainsway will offset losses from the drop in Brainsway's long position.
The idea behind Propanc Biopharma and Brainsway pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity